KR830004263A - 신규 소염제 및 면역 조절제인 피리딘과 피리미딘의 제조방법 - Google Patents

신규 소염제 및 면역 조절제인 피리딘과 피리미딘의 제조방법 Download PDF

Info

Publication number
KR830004263A
KR830004263A KR1019800003966A KR800003966A KR830004263A KR 830004263 A KR830004263 A KR 830004263A KR 1019800003966 A KR1019800003966 A KR 1019800003966A KR 800003966 A KR800003966 A KR 800003966A KR 830004263 A KR830004263 A KR 830004263A
Authority
KR
South Korea
Prior art keywords
formula
compound
hydrogen
phenyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019800003966A
Other languages
English (en)
Other versions
KR840001614B1 (ko
Inventor
죠지 롬바르디노 요세프
알몬 하버트 챨스
Original Assignee
에밀 안토니 아고스티니
화이자 인코포레이트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에밀 안토니 아고스티니, 화이자 인코포레이트 filed Critical 에밀 안토니 아고스티니
Publication of KR830004263A publication Critical patent/KR830004263A/ko
Priority to KR1019840005076A priority Critical patent/KR840001615B1/ko
Application granted granted Critical
Publication of KR840001614B1 publication Critical patent/KR840001614B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01D—HARVESTING; MOWING
    • A01D34/00—Mowers; Mowing apparatus of harvesters
    • A01D34/001—Accessories not otherwise provided for
    • A01D34/003—Means for cleaning the machine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C33/00—Moulds or cores; Details thereof or accessories therefor
    • B29C33/56—Coatings, e.g. enameled or galvanised; Releasing, lubricating or separating agents
    • B29C33/60—Releasing, lubricating or separating agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C70/00—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts
    • B29C70/68—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks
    • B29C70/84—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks by moulding material on preformed parts to be joined
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00—Pivots; Pivotal connections
    • F16C11/04—Pivotal connections
    • F16C11/06—Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/0604—Construction of the male part
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00—Pivots; Pivotal connections
    • F16C11/04—Pivotal connections
    • F16C11/06—Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/068—Special features relating to lubrication

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Environmental Sciences (AREA)
  • Composite Materials (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

내용 없음

Description

신규 소염제 및 면역 조절제인 피리딘과 피리미딘의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 다음 구조식(Ⅱ)의 화합물을 불활성 용매내에서 0내지 120℃의 온도로, 임의로 염기성 촉매의 존재하에서 반응이 완결될 때까지 구조식(Ⅲ)의 화합물 1당량과 반응시키거나 구조식(Ⅳ) 또는 구조식(Ⅴ)의 화합물을 불활성용매내에서 0내지 120℃의 온도로, 임의로 염기성 촉매의 존재하에서, 반응이 완결될때까지 구조식(Ⅵ)의 화합물 1당량과 반응시켜 구조식(Ⅰ)의 화합물을 제조하는 방법.
    상기 구조식에서
    V는 질소 또는 C-H이고
    n은 1또는 2의 정수이고
    Y는 0-페닐렌, 프로필렌, 에틸렌(메틸그룹 2 까지와 페닐그룹 1로 치환 또는 비치환됨),
    또는 X가 니트로 또는 메톡시인이고,
    R1은 수소, 메틸, 탄소수 2내지 5의 알카노일 또는 벤조일이고 Y가일 경우 R1은 수소이고.
    X'는 할라이드이다.
  2. 다음 구조식(Ⅱ) 또는 (Ⅲ)의 화합물을 불활성 용매내에서 0내지 100℃의 온도로 하이드라이드 환원을 시켜서 구조식(Ⅰ)의 화합물을 제조하는 방법.
    상기 구조식에서
    V는 질소 또는 C-H이고
    n은 1 또는 2의 정수이고
    W는 메틸렌(메틸그룹이나 페닐그룹으로 치환 또는 비치환된 것임)이고
    Z는 수소, 메틸 또는 페닐이고,
    W가 페닐로 치환될 경우, Z는 페닐이외의 것이고.
    R2는 탄소수 1내지 4의 알킬 또는 수소이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019800003966A 1979-10-15 1980-10-15 4-치환된 피리딘 및 피리미딘 유도체의 제조방법 Expired KR840001614B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019840005076A KR840001615B1 (ko) 1979-10-15 1984-08-22 4-치환된 피리딘 및 피리미딘 유도체의 제조방법

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85011 1979-10-15
US06/085,011 US4246263A (en) 1979-10-15 1979-10-15 Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1019840005076A Division KR840001615B1 (ko) 1979-10-15 1984-08-22 4-치환된 피리딘 및 피리미딘 유도체의 제조방법

Publications (2)

Publication Number Publication Date
KR830004263A true KR830004263A (ko) 1983-07-09
KR840001614B1 KR840001614B1 (ko) 1984-10-11

Family

ID=22188737

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019800003966A Expired KR840001614B1 (ko) 1979-10-15 1980-10-15 4-치환된 피리딘 및 피리미딘 유도체의 제조방법
KR1019840005076A Expired KR840001615B1 (ko) 1979-10-15 1984-08-22 4-치환된 피리딘 및 피리미딘 유도체의 제조방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1019840005076A Expired KR840001615B1 (ko) 1979-10-15 1984-08-22 4-치환된 피리딘 및 피리미딘 유도체의 제조방법

Country Status (39)

Country Link
US (1) US4246263A (ko)
JP (1) JPS5663962A (ko)
KR (2) KR840001614B1 (ko)
AR (3) AR226864A1 (ko)
AT (2) AT377513B (ko)
AU (1) AU517763B2 (ko)
BE (1) BE885709A (ko)
CA (1) CA1156231A (ko)
CH (1) CH646425A5 (ko)
CS (2) CS226020B2 (ko)
DD (2) DD154816B3 (ko)
DE (1) DE3038593A1 (ko)
DK (1) DK152427C (ko)
EG (1) EG14676A (ko)
ES (2) ES495932A0 (ko)
FI (1) FI75560C (ko)
FR (1) FR2467199A1 (ko)
GB (2) GB2061928B (ko)
GR (1) GR70311B (ko)
HK (2) HK1185A (ko)
HU (2) HU191824B (ko)
IE (1) IE50665B1 (ko)
IL (1) IL61261A (ko)
IN (2) IN154554B (ko)
IT (1) IT1195269B (ko)
KE (2) KE3461A (ko)
LU (1) LU82844A1 (ko)
MY (2) MY8500325A (ko)
NL (1) NL8005652A (ko)
NO (1) NO156566C (ko)
NZ (1) NZ195246A (ko)
PH (1) PH18277A (ko)
PL (2) PL125314B1 (ko)
PT (1) PT71917B (ko)
SE (1) SE437023B (ko)
SG (2) SG56384G (ko)
SU (2) SU1083907A3 (ko)
YU (2) YU41740B (ko)
ZA (1) ZA806306B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371696A (en) * 1980-07-14 1983-02-01 Pfizer Inc. Certain pyridine methylthio acetaldehyde derivatives and non-cyclic and cyclic acetals thereof
GB8405896D0 (en) * 1984-03-07 1984-04-11 Sandoz Ltd Organic compounds
EP0311616B1 (en) * 1986-06-17 1991-09-25 Biogen, Inc. Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents for treating diseases
WO2003024955A2 (en) * 2001-09-18 2003-03-27 Sunesis Pharmaceuticals, Inc. Small molecule inhibitors of caspases
PT1896401E (pt) * 2005-02-25 2013-07-17 Univ Temple Síntese de sulfuretos, sulfonas, sulfóxidos e sulfonamidas não saturados
TW200917961A (en) * 2007-08-23 2009-05-01 Sumitomo Chemical Co Fluorine-containing organosulfur compound and pesticidal composition thereof
CN108530606B (zh) * 2018-04-19 2020-11-20 山东师范大学 一种pH敏感性医用聚氨酯脲材料及其制备方法
WO2020076623A1 (en) 2018-10-08 2020-04-16 Ecolab Usa Inc. Sulfide-based compounds and uses thereof
CN110483740B (zh) * 2019-08-12 2021-08-27 山东师范大学 一种聚合物、pH敏感性纳米囊泡及制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3409626A (en) * 1963-09-17 1968-11-05 Neisler Lab Inc Indolylethyl pyridinium quaternary ammonium compounds
NL144484B (nl) * 1967-07-26 1975-01-15 Merck & Co Inc Werkwijze ter bereiding van een geneesmiddel met anti-anflammatoire werking, alsmede werkwijze ter bereiding van de anti-inflammatoir werkzame aralkylmercaptoaminozuren.
US3558640A (en) * 1967-12-20 1971-01-26 Merck & Co Inc Certain pyridyl and thiazolyl methylthiopropionic acids and derivatives
US3636074A (en) * 1968-08-05 1972-01-18 Hooker Chemical Corp Novel mercaptophenol derivatives
US3591584A (en) 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3818009A (en) * 1969-12-29 1974-06-18 Lilly Co Eli Alpha, alpha-disubstituted-5-pyrimidinemethanes
US3676463A (en) 1970-10-15 1972-07-11 Pfizer Oxobenzofuran carboxamides
US3707475A (en) 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
JPS52125170A (en) * 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives

Also Published As

Publication number Publication date
IL61261A (en) 1984-08-31
IE50665B1 (en) 1986-06-11
FI75560C (fi) 1988-07-11
AU6324080A (en) 1981-04-30
DE3038593C2 (ko) 1988-11-10
YU266882A (en) 1983-09-30
AT377513B (de) 1985-03-25
NO156566B (no) 1987-07-06
GR70311B (ko) 1982-09-08
FR2467199A1 (fr) 1981-04-17
IL61261A0 (en) 1980-12-31
IN163553B (ko) 1988-10-08
ES505544A0 (es) 1982-08-16
US4246263A (en) 1981-01-20
DK152427C (da) 1988-07-25
LU82844A1 (fr) 1981-06-04
NL8005652A (nl) 1981-04-21
AR226864A1 (es) 1982-08-31
ES8206478A1 (es) 1982-08-16
AR227576A1 (es) 1982-11-15
YU262680A (en) 1983-09-30
GB2092133A (en) 1982-08-11
IT8025324A0 (it) 1980-10-14
NO156566C (no) 1987-10-14
IE802125L (en) 1981-04-15
CH646425A5 (fr) 1984-11-30
DE3038593A1 (de) 1981-04-23
KE3466A (en) 1984-11-09
SE8007193L (sv) 1981-04-16
MY8500323A (en) 1985-12-31
SU1144617A3 (ru) 1985-03-07
ES8201972A1 (es) 1982-01-16
DK152427B (da) 1988-02-29
HK66887A (en) 1987-09-25
KE3461A (en) 1984-10-12
PL125314B1 (en) 1983-04-30
FI803239L (fi) 1981-04-16
SG69184G (en) 1985-03-15
PL125402B1 (en) 1983-05-31
AU517763B2 (en) 1981-08-27
EG14676A (en) 1985-03-31
HK1185A (en) 1985-01-11
DD154816A5 (de) 1982-04-21
BE885709A (fr) 1981-04-14
PH18277A (en) 1985-05-17
MY8500325A (en) 1985-12-31
ES495932A0 (es) 1982-01-16
GB2061928B (en) 1983-06-02
HU183233B (en) 1984-04-28
AT379801B (de) 1986-03-10
CS226034B2 (en) 1984-03-19
DD202543A5 (de) 1983-09-21
JPS6129342B2 (ko) 1986-07-05
PL227307A1 (ko) 1981-11-13
DK403080A (da) 1981-04-16
PT71917B (en) 1983-01-10
ATA268783A (de) 1985-07-15
HU191824B (en) 1987-04-28
ZA806306B (en) 1981-10-28
GB2092133B (en) 1983-03-16
CS226020B2 (en) 1984-03-19
SE437023B (sv) 1985-02-04
IT1195269B (it) 1988-10-12
DD154816B3 (de) 1987-05-13
KR840001615B1 (ko) 1984-10-11
PL231782A1 (ko) 1982-03-01
NO803073L (no) 1981-04-21
FI75560B (fi) 1988-03-31
GB2061928A (en) 1981-05-20
YU42059B (en) 1988-04-30
PT71917A (en) 1980-12-01
KR840001614B1 (ko) 1984-10-11
SG56384G (en) 1985-03-08
IN154554B (ko) 1984-11-10
NZ195246A (en) 1983-07-15
AR227089A1 (es) 1982-09-15
SU1083907A3 (ru) 1984-03-30
YU41740B (en) 1987-12-31
JPS5663962A (en) 1981-05-30
ATA508980A (de) 1984-08-15
CA1156231A (en) 1983-11-01
FR2467199B1 (ko) 1984-12-28

Similar Documents

Publication Publication Date Title
KR840005459A (ko) 메틸렌-디포스폰산 유도체의 제조방법
KR840004712A (ko) 벤조퀴논 유도체의 제조방법
KR860001058A (ko) 물성 향상제의 제조방법
KR830002699A (ko) 신규의 안트라센-9,10-비스-카르보닐-히드라존 및 그 유도체 제조방법
KR840000508A (ko) 4-아닐리노피리미딘 유도체의 제조방법
KR830004263A (ko) 신규 소염제 및 면역 조절제인 피리딘과 피리미딘의 제조방법
KR840005447A (ko) 밀베마이신 d 유도체의 제조방법
KR860007201A (ko) 항생 작용을 갖는 악타가르딘의 염기성 모노카르복시아미드 유도체의 제조방법
KR870002062A (ko) 2,3-디히드로-1h-인덴 유도체의 제조 방법
KR840004065A (ko) 2-시아노-2-프로페노산 및 그 유도체의 제조방법
KR830006302A (ko) 신규 피리미딘 유도체의 제조방법
KR830010083A (ko) 치환된 아세트 아닐리드 유도체의 제조방법
KR840006478A (ko) 벤조 트리아졸의 제조방법
KR850006188A (ko) 스피로-3-헤테로-아졸리딘디온의 제조방법
ES483249A1 (es) Procedimiento para la obtencion de diciclopentilen(2,2'-bis (4-alquil-6-t-butilfenoles).
KR830005097A (ko) N-치환된-2-할로아세트아닐리드의 제조방법
KR910011845A (ko) 2-푸릴피리미딘 유도체의 제조방법
KR860002474A (ko) 치환된 페닐술포닐아졸의 제조방법
KR950032107A (ko) 헤테로치환된 아세탈의 제조방법
KR860003204A (ko) 디페닐메틸이민 유도체의 제조방법
KR830006259A (ko) 2-아릴프로필에테르 유도체 및 티오에테르 유도체의 제조법과 살충, 살진드기제
KR860004024A (ko) 인돌 제조방법
KR830010096A (ko) 자일라이트 유도체의 제조방법
SE317077B (ko)
KR850006428A (ko) 에리드로마이신 아세트산염의 제조방법

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19891012

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19891012

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000